loss

Novo Nordisk A/S: CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published in New England Journal of Medicine

Data presented simultaneously at the American Diabetes Association’s® 85th Scientific Sessions, showed mean weight reduction in the highest range of…

2 weeks ago

Novo Nordisk: Higher dose of Wegovy provided average weight loss of 21% in people with obesity with a third achieving 25% or more according to data presented at ADA

Higher dose of Wegovy® provided average weight loss of 21% in people with obesity – with a third achieving 25%…

2 weeks ago

Novo Nordisks subcutaneous and oral amycretin data published in The Lancet and presented at ADA 2025

Subcutaneous amycretin phase 1b/2a data on the safety, tolerability and weight loss potential in people with overweight or obesity was…

2 weeks ago

New Survey Finds Younger Adults, More Women Seeking Treatment for Hair Loss

Manageable number of monthly hair restoration surgeries illustrates ISHRS members' hands-on, expert approach CHICAGO, June 10, 2025 /PRNewswire/ -- According to results…

3 weeks ago

The Ultimate Fathers Day Gift: Give Dad Confidence with a Full Head of Hair. Thursdays Hair Solutions Offers Complimentary First Service for Dads All June!

LOS ANGELES--(BUSINESS WIRE)--#Thursdays--This Father’s Day, Thursday’s Hair Solutions honors the men in our lives with more than just a card…

4 weeks ago

Ro Weight Loss Announces Official Website Update Featuring Natural Daily Program for Medically-Guided Weight Management

New York, June 07, 2025 (GLOBE NEWSWIRE) -- Ro Weight Loss, a digital health service from Roman Health Ventures Inc.,…

4 weeks ago